Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Econ Entomol ; 116(3): 835-847, 2023 06 13.
Artículo en Inglés | MEDLINE | ID: mdl-36964706

RESUMEN

The Nantucket pine tip moth (NPTM) (Rhyacionia frustrana Comstock) is a native, regeneration pest of young loblolly pines (Pinus taeda L.), causing shoot dieback, tree deformity, and growth and volume declines. Soil applications of systemic insecticides may be an effective strategy to suppress NPTM populations. The study objective was to assess the efficacy of four systemic insecticide treatments (chlorantraniliprole, dinotefuran, fipronil, and imidacloprid) for two growing seasons in outplanted bareroot and containerized seedling trials. Response variables included NPTM infestation rates, along with tree height, groundline diameter, volume index, and stem form. Infestation rates significantly decreased for each systemic insecticide treatment during the first year compared to controls, although dinotefuran and imidacloprid provided season-long control in one trial. Chlorantraniliprole reduced NPTM infestation rates for two growing seasons in both trials. While imidacloprid treatments did not alter growth metrics except for one comparison, fipronil and dinotefuran treatments improved several growth metrics. Chlorantraniliprole consistently improved growth metrics throughout the study.


Asunto(s)
Insecticidas , Mariposas Nocturnas , Pinus , Animales , Pinus taeda , Mariposas Nocturnas/fisiología , Benchmarking , Control de Insectos , Árboles
2.
Pharmacogenomics J ; 14(5): 481-7, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24567120

RESUMEN

At the blood-brain barrier, overexpression of the drug efflux transporter ABCC2 (also known as MRP2) has been proposed as a mechanism for impaired carbamazepine (CBZ) treatment response in epilepsy. However, investigation of the impact of ABCC2 polymorphisms on CBZ treatment efficacy has produced conflicting and inconclusive results. A series of in vitro cell efflux and plasma membrane vesicle uptake assays were undertaken to investigate whether CBZ was an ABCC2 substrate. In addition, the effect of three common ABCC2 polymorphisms, -24C>T, c.1249G>A and c.3972C>T, on the efficacy of CBZ in epilepsy (assessed using the clinical end points time to first seizure and time to 12-month remission from the SANAD (Standard and New Antiepileptic Drugs) trial) was determined. CBZ was found not to be a substrate for human ABCC2 in vitro. Clinically, no significant association was observed for the ABCC2 genetic variants and CBZ treatment outcomes. This comprehensive analysis does not support a role for ABCC2 in CBZ treatment efficacy.


Asunto(s)
Carbamazepina/uso terapéutico , Epilepsia/tratamiento farmacológico , Epilepsia/genética , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Adulto , Femenino , Humanos , Masculino , Proteína 2 Asociada a Resistencia a Múltiples Medicamentos , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo , Polimorfismo Genético/genética , Células Tumorales Cultivadas
3.
J Pediatr Orthop ; 28(6): 607-13, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18724195

RESUMEN

BACKGROUND: When closed reduction of a developmental dislocation of the hip fails, some form of open reduction is required. In recent years, the many advantages of the medial approach open reduction have been emphasized. However, there have been suggestions that the rate of growth disturbance in the proximal femur and the requirement for secondary surgical procedures may be higher with this route than with others. The purpose of this study was to investigate the efficacy and safety of a modified medial approach open reduction, in which the stability of the reduction is enhanced by resection of the redundant ligamentum teres and suturing of the stump of the tendon to the anteromedial capsule. METHODS: The hospital records and radiographs of 92 infants and children with 109 dislocated hips were reviewed retrospectively. Key demographic and pretreatment data were collected by the first author and compared with the outcome at the most recent follow-up. In addition, 69 children returned for a clinical evaluation by the first author. The outcome at the most recent follow-up was graded according to Severin, and associations were sought between pretreatment grade of dislocation according to Tonnis, the presence of ossific nucleus, changes in the acetabular index, the requirements for secondary surgery, associations with previous treatment, and the position of abduction in the postoperative cast. RESULTS: At a mean follow-up of 9 years, 89% of hips were classified as Severin grade 1 or 2. Avascular necrosis (AVN) was classified according to the system of Kalamchi and MacEwen. The incidence of AVN was 41%, but two thirds of these were grade 1 (temporary irregular ossification), and the Severin grading in these hips was not compromised. The presence of ossification in the capital epiphysis and a range of abduction of less than 60 degrees in the hip spica were noted to be protective against the development of AVN. Three hips redislocated and required additional treatment. Thirty-eight hips required a total of 44 additional surgical procedures. CONCLUSIONS: We have demonstrated that it is possible to use a medial approach for open reduction of the congenitally dislocated hip in combination with tenodesis of the ligamentum teres to the anteromedial joint capsule. The incidence of growth disturbance in the proximal femur is high and cumulative with long-term follow-up. However, in this large series, the rate of hip stability, growth disturbance, and need for secondary surgery are comparable to other series. We conclude that the many advantages of open reduction by the medial approach outweigh the disadvantages.


Asunto(s)
Necrosis de la Cabeza Femoral/etiología , Luxación Congénita de la Cadera/cirugía , Tenodesis/métodos , Niño , Preescolar , Femenino , Fémur/crecimiento & desarrollo , Estudios de Seguimiento , Luxación Congénita de la Cadera/clasificación , Luxación Congénita de la Cadera/patología , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Rango del Movimiento Articular , Reoperación , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Tenodesis/efectos adversos , Resultado del Tratamiento
4.
J Rheumatol ; 28(9): 2120-4, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11550985

RESUMEN

Macrophage activation syndrome (MAS), a recognized complication of systemic juvenile rheumatoid arthritis (sJRA), has been associated with significant morbidity and mortality. Dysregulation of macrophage-lymphocyte interactions leading to uncontrolled proliferation of highly activated macrophages and massive release of proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) appears to be central to the pathogenesis of this syndrome. Until now the mainstay of therapy has been corticosteroids and cyclosporin A. We describe a patient with MAS and sJRA successfully treated with the anti-TNF agent etanercept. The outcome in this patient suggests etanercept might be an effective therapeutic agent in MAS.


Asunto(s)
Artritis Juvenil/diagnóstico , Artritis Juvenil/tratamiento farmacológico , Inmunoglobulina G/administración & dosificación , Activación de Macrófagos/efectos de los fármacos , Receptores del Factor de Necrosis Tumoral/administración & dosificación , Antiinflamatorios no Esteroideos/administración & dosificación , Artritis Juvenil/complicaciones , Biopsia con Aguja , Médula Ósea/patología , Niño , Esquema de Medicación , Quimioterapia Combinada , Etanercept , Estudios de Seguimiento , Humanos , Activación de Macrófagos/fisiología , Masculino , Medición de Riesgo , Índice de Severidad de la Enfermedad , Piel/patología , Síndrome , Resultado del Tratamiento
5.
Br J Cancer ; 83(12): 1599-606, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11104552

RESUMEN

CT-2584 HMS, 1-(11-dodecylamino-10-hydroxyundecyl)-3, 7-dimethylxanthine-hydrogen methanesulphonate, is a modulator of intracellular phosphatidic acid. We treated 30 patients as part of a Phase I and pharmacokinetic study to determine the maximum-tolerated dose of CT-2584 HMS, toxicity profiles, pharmacokinetic profile and antitumour effects at escalating dose levels. CT-2584 HMS was given as a continuous infusion for 6 hours for 5 consecutive days every 3 weeks. Plasma samples for pharmacokinetic studies were analysed using a validated high-performance liquid chromatographic assay. Mean C(max)and AUC values for each dose group were similar on days 1 and 5 and increases in plasma concentration (C(max)and AUC) appeared proportional to the dose. CT-2584 HMS had a mean elimination half-life of 7.3 hours. Values of V(d)and clearance were independent of dose and duration of treatment. Dose escalation was halted at 585 mg/m(2)because of malaise and lethargy, which was sometimes accompanied by nausea and headache. 26 patients were evaluable for response, one patient with pleural mesothelioma achieved a partial response to treatment confirmed by CT scanning. A dose level of 520 mg/m(2)daily x 5 days would be suitable for Phase II testing. Alternative schedules of CT-2584 HMS to overcome the limiting toxicity of malaise would be worthy of examination.


Asunto(s)
Antineoplásicos/farmacocinética , Neoplasias/tratamiento farmacológico , Ácidos Fosfatidicos/metabolismo , Xantinas/farmacocinética , Adulto , Anciano , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Área Bajo la Curva , Arritmias Cardíacas/inducido químicamente , Relación Dosis-Respuesta a Droga , Fatiga/inducido químicamente , Femenino , Hematuria/inducido químicamente , Humanos , Hipersensibilidad/etiología , Hipotensión/inducido químicamente , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Isquemia Miocárdica/inducido químicamente , Náusea/inducido químicamente , Neoplasias/sangre , Proteinuria/inducido químicamente , Resultado del Tratamiento , Vómitos/inducido químicamente , Xantinas/efectos adversos , Xantinas/uso terapéutico
6.
J Pediatr Orthop ; 20(3): 336-43, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10823601

RESUMEN

We reviewed the clinical and radiologic results of 164 proximal femoral osteotomies in 132 children using the AO (ASIF) 90 degree fixed-angle blade plate and the Richards intermediate hip screw to establish the clinical and radiologic outcomes, establish the incidence of complications, and determine the relative indications and contraindications for the two implants. The incidence of complication in this series was 9% (15 complications in 14 osteotomies in 13 patients) including one bursitis, one wound breakdown with exposure of the underlying plate, five infections, two peroneal nerve palsies, one fractured shaft of femur, one fractured neck of femur, two technical errors, one painful nonunion, and one loss of fixation. There were five (3%) revisions in total. Fifty-six osteotomies in 44 patients were performed using the Richards intermediate hip screw, and 108 osteotomies were performed in 88 patients using the AO 90 degree fixed-angle blade plate. We found that both implants were effective with an acceptable rate of complications and revision surgery.


Asunto(s)
Placas Óseas , Tornillos Óseos , Fémur/cirugía , Osteotomía , Adolescente , Adulto , Parálisis Cerebral/cirugía , Niño , Preescolar , Femenino , Luxación de la Cadera/cirugía , Humanos , Enfermedad de Legg-Calve-Perthes/cirugía , Masculino , Complicaciones Posoperatorias
7.
J Pediatr Orthop B ; 9(1): 47-9, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10647110

RESUMEN

Outcomes from observation or cast or surgical treatment of idiopathic toe-walking were determined in 136 children. With patient-determined outcomes, for the observation group, gait was normal in 6%, improved in 45%, and unchanged in 49%. Physician-determined outcomes demonstrated normal gait in 12% of children. Outcomes were similar in the cast group. With patient-determined outcomes in the surgical group, 22% walked normally, 50% had improved, 26% were unchanged, and 2% had deteriorated; with physician-determined outcomes, 37% walked normally. The natural history, determined from the observation group, was for idiopathic toe-walking to persist, albeit with improvement in 50%. Cast treatment did not alter the natural history. Surgical treatment may influence the outcome, but indications for surgery need to be clarified.


Asunto(s)
Tendón Calcáneo/anomalías , Marcha , Dedos del Pie , Tendón Calcáneo/cirugía , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Resultado del Tratamiento
8.
Issues Compr Pediatr Nurs ; 23(3): 155-64, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11310235

RESUMEN

The Health Council of Hawkins County, Tennessee, received a State Tobacco Prevention grant to institute an anti-smoking program in the county schools. The program chosen was called TarWars and encompasses a prohealth tobacco-free program curriculum. The goal was to discourage tobacco use among the nation's youth by focusing on tobacco's short-term ill effects. Because the program encourages community involvement, nursing students from East Tennessee State University, Johnson City, identified volunteers from the Hawkins County Retired Teachers Association to develop a teaching program for use in the first year of the program and as well as in subsequent years of the TarWars curriculum. A pretest and posttest were given to the students to assess the program's success. The objectives of the grant were that 80% of the students would be able to name three negative effects associated with tobacco use and three positive effects of not using tobacco. The goal was met when 91% could identify negative effects and 89% could identify three positive effects of not using tobacco.


Asunto(s)
Bachillerato en Enfermería , Servicios de Salud Escolar/organización & administración , Servicios de Enfermería Escolar/organización & administración , Prevención del Hábito de Fumar , Estudiantes de Enfermería , Niño , Humanos , Servicios de Salud Rural/organización & administración , Tennessee
10.
J Pediatr Orthop B ; 6(3): 215-8, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9260653

RESUMEN

The cause of toe-walking is unknown. Muscle biopsies were taken from a group of 25 toe-walkers who were treated at this hospital to try to identify the pathological cause of the condition. The most common abnormality noted was an increase in the proportion of type I muscle fibers with type grouping; other less common changes included the presence of angulated atrophic fibers and thickened capillaries and cases in which occasional fibers were undergoing active degeneration and regeneration. The combination of these changes suggests that there may be an underlying neuropathic process in idiopathic toe-walkers.


Asunto(s)
Marcha , Músculo Esquelético/anomalías , Músculo Esquelético/patología , Dedos del Pie , Caminata , Biopsia con Aguja , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA